Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jul;90(7):371-4.
doi: 10.1177/014107689709000704.

Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients

Affiliations

Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients

J T Lear et al. J R Soc Med. 1997 Jul.

Abstract

Basal cell carcinoma (BCC) is the commonest malignant neoplasm in white people. We present a large UK case-control study in which conditional logistic regression analysis of age-matched and gender-matched data sets was used to compare, first, cases with controls (n = 403) and second, patients having multiple BCC with those having a single BCC (n = 278). Eye/hair colour, occupation, skin type, social class, tumour site at presentation and smoking history were assessed. Social class 1/2, skin type 1, red/blonde hair and blue/green eyes were all related to BCC risk, social class most strongly (odds ratio 2.36, P = 0.007). Truncal site at presentation was a risk factor for the development of multiple BCC (odds ratio 4.03, P = 0.002). These data support the view that genetically mediated differences in ultraviolet responsiveness are important in BCC, though the scale of their effect is small. They may be exploitable in primary and secondary prevention as well as giving insights into pathogenesis. In particular, the fact that patients presenting with a truncal tumour are at increased risk of further BCC suggests that intermittent exposure in genetically predisposed individuals may contribute to a cancer susceptibility syndrome.

PubMed Disclaimer

References

    1. CA Cancer J Clin. 1994 Jan-Feb;44(1):7-26 - PubMed
    1. Cancer Res. 1994 Jan 15;54(2):437-40 - PubMed
    1. J Am Acad Dermatol. 1994 May;30(5 Pt 1):774-8 - PubMed
    1. Cancer Res. 1994 Sep 1;54(17):4756-9 - PubMed
    1. Arch Dermatol. 1995 Feb;131(2):157-63 - PubMed

Publication types